1140-69-8

Basic information

• Product Name: 1H-Pyrazole-3-carboxylic acid, 2,5-dihydro-5-oxo-2-phenyl-, methyl ester
• CAS NO: 1140-69-8
• Molecular Formula: C11H10N2O3
• Molecular Weight: 218.212
• Mol File: 1140-69-8.mol

Chemical Properties

• CAS DataBase Reference: 1H-Pyrazole-3-carboxylic acid, 2,5-dihydro-5-oxo-2-phenyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole-3-carboxylic acid, 2,5-dihydro-5-oxo-2-phenyl-, methyl ester(1140-69-8)
• EPA Substance Registry System: 1H-Pyrazole-3-carboxylic acid, 2,5-dihydro-5-oxo-2-phenyl-, methyl ester(1140-69-8)

Safety Data

• Hazardous Substances Data: 1140-69-8(Hazardous Substances Data)

Usage

Type of compound

Methyl ester derivative of pyrazole-3-carboxylic acid

Contains

A phenyl group

Usage

Organic synthesis and medicinal chemistry

Purpose

Building block for the preparation of various pharmaceuticals and bioactive compounds

Biological activities

Potential anti-inflammatory, anticancer, and antimicrobial properties

Applications

Development of new drugs and agrochemicals

Upstream product

• 3950-18-3 3-hydroxy-1-phenyl-1H-pyrazole-5-carboxylic acid 
• 100-63-0 phenylhydrazine 
• 762-42-5 dimethyl acetylenedicarboxylate 
• 464185-42-0 methyl 3-benzyloxy-1-phenyl-1H-pyrazole-5-carboxylate 

Downstream Products

• 464185-42-0 methyl 3-benzyloxy-1-phenyl-1H-pyrazole-5-carboxylate 
• 92576-30-2 methyl 3-methoxy-1-phenyl-1H-pyrazole-5-carboxylate 

Relevant articles and documents

CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF

Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.

HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF

Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, compositions thereof, and methods of their use.

1,2-AZOLE DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY

A compound represented by the formula (1) wherein ring A is a ring optionally having 1 to 3 substituents; ring B is a 1,2-azole ring which may further have 1 to 3 substituents; Xa, Xb and Xc are the same or different and each is a bond, - O -, - S - and the like; Ya is a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; Yb and Yc are the same or different and each is a bond or a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; ring C is a monocyclic aromatic ring which may further have 1 to 3 substituents; and R represents -OR4 (R4 is hydrogen atom or optionally substituted hydrocarbon group) and the like, or a salt thereof or a prodrug thereof is useful as an agent for the prophylaxis or treatment of diabetes and the like.